Stock Earnings

Question 1

Viridian Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Viridian Therapeutics Inc'in toplam varlıkları $742 olup, net loss $-269'dir.

Question 2

VRDN'ün temel finansal oranları nelerdir?

Accepted Answer

Viridian Therapeutics Inc'in cari oranı 10.6, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Viridian Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Viridian Therapeutics Inc largest revenue segment is Monoclonal Antibody, at a revenue of 302,000 in the most earnings release.For geography, United States is the primary market for Viridian Therapeutics Inc, at a revenue of 302,000.

Question 4

Viridian Therapeutics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Viridian Therapeutics Inc'in net loss $-269'dir.

Question 5

Viridian Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Viridian Therapeutics Inc'in yükümlülüğü 70'dir.

Question 6

Viridian Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Viridian Therapeutics Inc'in toplam tedavüldeki hisse sayısı 80.99'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	1	2	1
Revenue Growth (YoY)	--	--	-100%	-50%	100%	-75%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	67	61	94	35	25	13
Research & Development	304	237	159	100	56	27
Operating Expenses	371	299	254	136	82	41
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-344	-269	-237	-129	-79	-110
Income Tax Expense	--	--	--	--	--	--
Net Income	-344	-269	-237	-129	-79	-110
Net Income Growth	51%	14%	84%	63%	-28%	168%
Shares Outstanding (Diluted)	81.59	67.88	44.75	32.09	11.92	3.56
Shares Change (YoY)	28%	52%	39%	169%	235%	70%
EPS (Diluted)	-4.21	-3.97	-5.31	-4.05	-6.66	-31.1
EPS Growth	18%	-25%	31%	-39%	-79%	55%
Free Cash Flow	-309	-232	-185	-94	-54	-29
Free Cash Flow Per Share	-3.78	-3.41	-4.13	-2.92	-4.53	-8.14
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-13,400%	-3,950%	-4,000%
Profit Margin	0%	0%	0%	-12,900%	-3,950%	-11,000%
Free Cash Flow Margin	0%	0%	0%	-9,400%	-2,700%	-2,900%
EBITDA	-371	-299	-254	-134	-79	-40
EBITDA Margin	0%	0%	0%	-13,400%	-3,950%	-4,000%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-371	-299	-254	-134	-79	-40
EBIT Margin	0%	0%	0%	-13,400%	-3,950%	-4,000%
Effective Tax Rate	--	--	--	--	--	--

Viridian Therapeutics Inc (VRDN) Price

VRDN Stock Price Chart

VRDN Income

Follow-Up Questions